Alembic Pharmaceuticals : Disclosure of other UPSI/material event
October 24, 2022 at 11:53 pm EDT
Share
Date: 25th October, 2022
To,
The Manager,
Listing Department,
National Stock Exchange of India Ltd.
'Exchange Plaza', Bandra Kurla Complex,
Bandra (E), Mumbai - 400 051
Dear Sir / Madam,
Sub: Successful completion of USFDA inspection at Alembic Pharmaceuticals' Bioequivalence Facility at Vadodara
We would like to inform the exchange that the Company has successfully completed the United States Food and Drug Administration (USFDA) inspection for its Bioequivalence Facility located at Vadodara without any observations. The inspection was conducted from 17th October, 2022 to 21st October, 2022.
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Alembic Pharmaceuticals Limited
CHARANDEEP SINGH SALUJA
Digitally signed by CHARANDEEP SINGH SALUJA DN: c=IN, o=Personal, pseudonym=a60bda6662cacaa6dee424354752c8af217d06e3e0b6cc73c4 bb1acdf09b43c5, postalCode=390008, st=GUJARAT, serialNumber=2df2425a9d726770b96178ea7d183d3b13c8557e9c4be4aa f90236628eb533e7, cn=CHARANDEEP SINGH SALUJA
Alembic Pharmaceuticals Limited published this content on 25 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 October 2022 03:52:06 UTC.
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is involved in manufacturing and marketing India Formulations, International Generics, and Active Pharmaceutical Ingredients (API). It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology. Products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its India Formulations. Its subsidiaries include Alembic Pharmaceuticals Inc., Alembic Global Holding SA and others.
ALEMBIC PHARMACEUTICALS LIMITED 
